Cerebrospinal Fluid Neopterin in Children With Enterovirus-Related Brainstem Encephalitis.


Journal

Pediatric neurology
ISSN: 1873-5150
Titre abrégé: Pediatr Neurol
Pays: United States
ID NLM: 8508183

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 09 2018
revised: 29 01 2019
accepted: 31 01 2019
pubmed: 3 4 2019
medline: 2 5 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

Enterovirus-A71 causes outbreaks of brainstem encephalitis, ranging from self-limited disease to acute flaccid paralysis. The aim of this study was to assess the role of cerebrospinal fluid (CSF) neopterin as a biomarker of disease severity in children with enterovirus-related brainstem encephalitis. A descriptive, prospective cohort study was conducted from April 2016 to March 2017 in a tertiary hospital. Pediatric patients with a diagnosis of brainstem encephalitis with or without myelitis due to enterovirus infection were enrolled. The final study group comprised a convenience sample including all patients with sufficient CSF volume for neopterin determination. The major variables considered in estimating the severity were the diagnosis of encephalomyelitis, the presence of lesions and extensive lesions on brain and spinal magnetic resonance imaging (MRI), hospital stay length greater than seven days, and sequelae at day 30. Of 60 patients, CSF neopterin could be measured in 36. Median age was 26 months (interquartile range: 19 to 32). Thirty-three were diagnosed with brainstem encephalitis and three with encephalomyelitis. Enterovirus-A71 was the only identified genotype (25 of 25). CSF neopterin levels were elevated (>61 nmol/L) in 33 of 36 (92%), with a median of 347 nmol/L (interquartile range: 204 to 525). CSF neopterin was useful to distinguish patients with lesions on MRI (area under the receiver operating characteristic curve = 0.76; P = 0.02) and extensive lesions (area under the receiver operating characteristic curve = 0.76; P = 0.04). This study suggests an association between CSF neopterin levels and the presence of inflammatory lesions on MRI.

Sections du résumé

BACKGROUND
Enterovirus-A71 causes outbreaks of brainstem encephalitis, ranging from self-limited disease to acute flaccid paralysis. The aim of this study was to assess the role of cerebrospinal fluid (CSF) neopterin as a biomarker of disease severity in children with enterovirus-related brainstem encephalitis.
METHODS
A descriptive, prospective cohort study was conducted from April 2016 to March 2017 in a tertiary hospital. Pediatric patients with a diagnosis of brainstem encephalitis with or without myelitis due to enterovirus infection were enrolled. The final study group comprised a convenience sample including all patients with sufficient CSF volume for neopterin determination. The major variables considered in estimating the severity were the diagnosis of encephalomyelitis, the presence of lesions and extensive lesions on brain and spinal magnetic resonance imaging (MRI), hospital stay length greater than seven days, and sequelae at day 30.
RESULTS
Of 60 patients, CSF neopterin could be measured in 36. Median age was 26 months (interquartile range: 19 to 32). Thirty-three were diagnosed with brainstem encephalitis and three with encephalomyelitis. Enterovirus-A71 was the only identified genotype (25 of 25). CSF neopterin levels were elevated (>61 nmol/L) in 33 of 36 (92%), with a median of 347 nmol/L (interquartile range: 204 to 525). CSF neopterin was useful to distinguish patients with lesions on MRI (area under the receiver operating characteristic curve = 0.76; P = 0.02) and extensive lesions (area under the receiver operating characteristic curve = 0.76; P = 0.04).
CONCLUSIONS
This study suggests an association between CSF neopterin levels and the presence of inflammatory lesions on MRI.

Identifiants

pubmed: 30935719
pii: S0887-8994(18)30986-X
doi: 10.1016/j.pediatrneurol.2019.01.024
pii:
doi:

Substances chimiques

Neopterin 670-65-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-73

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Dídac Casas-Alba (D)

Department of Pediatrics, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain; Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.

Ana Valero-Rello (A)

Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; Department of Molecular Microbiology, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain.

Jordi Muchart (J)

Department of Diagnostic Imaging, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain.

Thaís Armangué (T)

Pediatric Neuroimmunology Unit, Department of Pediatric Neurology, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain; Neuroimmunology Program, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-Hospital Clinic (University of Barcelona), Barcelona, Spain; CIBER en Enfermedades Raras (CIBERER), Madrid, Spain.

Iolanda Jordan (I)

Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Pediatric Intensive Care Unit, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain.

María Cabrerizo (M)

Enterovirus Unit, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

Marta Molero-Luís (M)

CIBER en Enfermedades Raras (CIBERER), Madrid, Spain; Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.

Rafael Artuch (R)

Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.

Claudia Fortuny (C)

Department of Pediatrics, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain; Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Carmen Muñoz-Almagro (C)

Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; Department of Molecular Microbiology, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.

Cristian Launes (C)

Department of Pediatrics, Hospital Sant Joan de Deu (University of Barcelona), Barcelona, Spain; Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de Deu, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: claunes@sjdhospitalbarcelona.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH